socaltech | Shared With: Everyone - Aug 08 2006 | cabrellis, cancer, lung, domain, associates, venture, capital, vc, investment, funding, anthracycline, socaltechSan Diego-based Cabrellis Pharmaceuticals, which is developing treatments for cancer, said Monday that it has raised $27.5M in a Series A funding round. Funding came from Domain Associates, Forward Ventures, Lilly Ventures, Novo A/S, ProQuest Investments,
Related Content from Around Faves
funding
-
1 FaverViewed: 4 TimesQuoted: There are two forms of exotic beta. 1) Apply "normal" strategies to "exotic" assets like investing in Namibian and Mongolian equities, timber, shipping freight, wine, uranium, art, movies, violins or footballers. Or 2) apply "exotic" strategies to "normal" securities with new trading styles and finding arbitrages in traditional markets. Personally I prefer alternative strategies for any security ("normal" or "exotic") but then as a risk averse, conservative investor I am not prepared to speculate on traditional OR exotic beta. They are too hazardous for my risk tolerance. Alpha is safer.
- inform36 - Mar 06 20082 FaversViewed: 3 Times
- AdEmp - 18 days ago1 Faver
vcs
-
Interesting
1 FaverViewed: 4 TimesQuoted: The news that some Facebook employees are selling their stock privately naturally focuses on the price/valuation (a deep discount to the $15bn that Microsoft paid).
- mohit - 5 days ago2 FaversViewed: 6 Times
- mohit - Oct 10 20081 FaverViewed: 2 Times
